Chronic myeloid leukemia stem cells: targeting therapeutic implications
Abstract Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasm driven by BCR-ABL1 oncoprotein, which plays a pivotal role in CML pathology, diagnosis, and treatment as confirmed by the success of tyrosine kinase inhibitor (TKI) therapy. Despite advances in the development of more po...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2021-12-01
|
| Col·lecció: | Stem Cell Research & Therapy |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s13287-021-02659-1 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|